title: [Characteristics of supposedly bacterial community acute pneumonia among HIV-positive patients: prospective preliminary study].
abstract: BACKGROUND
  Community-acquired pneumonia (CAP) is the second leading cause of hospitalization in the respirology department in Abidjan after tuberculosis. Frequently associated with HIV infection, it has a high mortality rate of about 20% to 30%. The aim of this study is to identify the specificities and severity factors associated with bacterial CAP (BCAP) outcome in HIV-positive patients.
  
  
  METHODS
  The authors conducted a prospective and comparative preliminary study on two groups of patients: 29 HIV-positive patients with BCAP and 21 HIV-negative patients with BCAP. All of the patients were hospitalized for BCAP with symptoms of severity according to the usual score of severity.
  
  
  RESULTS
  The sociodemographic, clinical and paraclinical characteristics were similar in both groups. Failures and deaths were more frequent in the group with HIV infection. In particular, HIV infected patients with a body mass index under 18.5 and a rate of T CD4 lymphocytes lower than 200/mm(3) presented the least favourable evolution.
  
  
  CONCLUSIONS
  A more extensive study should help define the appropriate severity criteria for BCAP associated with HIV infection.
authors.affiliation: Service de pneumologie, CHU de Cocody, 22 BP 917, Abidjan 22, Côte d'Ivoire. kigninlmanh@yahoo.fr
authors.forename: K
authors.initials: K
authors.lastname: Horo
authors.forename: V C
authors.initials: VC
authors.lastname: Gode
authors.forename: J M B
authors.initials: JM
authors.lastname: Ahui
authors.forename: A B
authors.initials: AB
authors.lastname: Kouassi
authors.forename: G B
authors.initials: GB
authors.lastname: Djereke
authors.forename: M
authors.initials: M
authors.lastname: Cardenat
authors.forename: A
authors.initials: A
authors.lastname: N'gom
authors.forename: N
authors.initials: N
authors.lastname: Koffi
authors.forename: E
authors.initials: E
authors.lastname: Aka-Danguy
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000401:mortality*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015992:Body Mass Index; D018791:CD4 Lymphocyte Count; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000401:mortality; D005260:Female; D015658:HIV Infections / Q000401:mortality*; D006801:Humans; D008297:Male; D011014:Pneumonia / Q000188:drug therapy / Q000401:mortality*; D011446:Prospective Studies; D012720:Severity of Illness Index
chemical_list: D000900:Anti-Bacterial Agents